Latest filing published 02 Jul 2015 for NORTHWEST BIOTHERAPEUTICS INC, €2.3M.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -19.6%Entry US$5.78 · Close at T+365 US$4.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Cognate Bioservices, Inc.: trading record in brief
Cognate Bioservices, Inc. is a declared insider of Northwest Biotherapeutics Inc, with filings sourced from SEC (Form 4). We count 70 filings; the first trade dates from 28 September 2009 and the latest from 30 June 2015.
Market trades split into 34 purchases (€9.0M) and 19 sales (€14.1M). The amount is not disclosed for 31 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants. So far in 2015, the count stands at no purchases and 2 sales.
Half of the purchases are above €243k and half below. Ninety days after publication, 3 purchases show a median change of +30.4%, with the price up in 100% of them. This is a record of the past, not a forecast.
The newest entry dates from 2 July 2015: an open-market sale of €2.3M, in Northwest Biotherapeutics Inc. The clock since the last published purchase (22 December 2014) now reads 4,339 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Cognate Bioservices, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 650,000 shares@ US$4.00Common Stock, par value $0.001SEC:0001144204-15-040971:0
- 1,118,092 shares@ US$4.22Common Stock, par value $0.001SEC:0001144204-15-040971:1
- 389,611 sharesCommon stock, par value $0.001 per share ("Common Stock")SEC:0001144204-14-075196:0Canonical exit: 30 May 2014 (T+90)
- 289,531 sharesCommon StockSEC:0001144204-14-075196:3Canonical exit: 30 Jun 2014 (T+90)
- 341,971 sharesCommon StockSEC:0001144204-14-075196:4Canonical exit: 30 Jul 2014 (T+90)
- 385,320 sharesCommon StockSEC:0001144204-14-075196:5Canonical exit: 30 Aug 2014 (T+90)
- 562,500 sharesCommon StockSEC:0001144204-14-075196:6Canonical exit: 28 Sept 2014 (T+90)
- 796,879 sharesCommon StockSEC:0001144204-14-075196:7Canonical exit: 29 Sept 2014 (T+90)
- 550,219 sharesCommon StockSEC:0001144204-14-075196:8Canonical exit: 30 Oct 2014 (T+90)
- 639,108 sharesCommon StockSEC:0001144204-14-075196:10Canonical exit: 30 Nov 2014 (T+90)
- 1,330,057 sharesCommon StockSEC:0001144204-14-075195:1
- 277,199 sharesCommon stock, par value $0.001 per share ("Common Stock")SEC:0001144204-14-075195:0Canonical exit: 1 Mar 2014 (T+90)
- 238,248 sharesCommon StockSEC:0001144204-14-075195:2Canonical exit: 1 Apr 2014 (T+90)
- 5,101,366 sharesCommon StockSEC:0001144204-14-075195:3Canonical exit: 17 Apr 2014 (T+90)
- 500,000 sharesCommon StockSEC:0001144204-14-075195:5Canonical exit: 2 May 2014 (T+90)
- 287,055 sharesCommon StockSEC:0001144204-14-075195:6Canonical exit: 2 May 2014 (T+90)
- 289,531 sharesCommon StockSEC:0001144204-14-075189:3Canonical exit: 30 Jun 2014 (T+90)
- 341,971 sharesCommon StockSEC:0001144204-14-075189:4Canonical exit: 30 Jul 2014 (T+90)
- 385,320 sharesCommon StockSEC:0001144204-14-075189:5Canonical exit: 30 Aug 2014 (T+90)
- 562,500 sharesCommon StockSEC:0001144204-14-075189:6Canonical exit: 28 Sept 2014 (T+90)
- 796,879 sharesCommon StockSEC:0001144204-14-075189:7Canonical exit: 29 Sept 2014 (T+90)
- 550,219 sharesCommon StockSEC:0001144204-14-075189:8Canonical exit: 30 Oct 2014 (T+90)
- 639,108 sharesCommon StockSEC:0001144204-14-075189:10Canonical exit: 30 Nov 2014 (T+90)
- 149,502 shares@ US$5.02Common StockSEC:0001144204-14-075189:11
- 1,330,057 sharesCommon StockSEC:0001144204-14-075188:1
25 of 62 declarations